How do anticoagulants impact the management of systemic lupus erythematosus (SLE) patients, particularly in preventing thrombotic complications associated with the condition?
Gaurav ChauhanContributor
How do anticoagulants impact the management of patients with systemic lupus erythematosus (SLE)?
Share
Anticoagulants are essential in managing SLE patients with antiphospholipid syndrome (APS), reducing the risk of thrombosis, a common and serious complication of SLE.